Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab with or without Estrogen Deprivation in Treating Patients with Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeAgeTrial IDs
Phase IIITreatment18 and overNSABP B-52
NCI-2013-02228, NCT02003209

Trial Description

Summary

This randomized phase III trial studies docetaxel, carboplatin, trastuzumab, and pertuzumab with estrogen deprivation to see how they work compared to docetaxel, carboplatin, trastuzumab, and pertuzumab without estrogen deprivation in treating patients with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive, operable or locally advanced breast cancer. Drugs used in chemotherapy, such as docetaxel, carboplatin, trastuzumab, and pertuzumab, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin acetate and aromatase inhibition therapy may fight breast cancer by blocking the use of estrogen by the tumor cells. Radiation therapy uses high energy x rays to kill tumor cells. Giving combination chemotherapy and radiation therapy with or without hormone therapy may be an effective treatment for hormone receptor-positive, HER2-positive, operable or locally advanced breast cancer.

Further Study Information

PRIMARY OBJECTIVES:

I. To determine whether the addition of estrogen deprivation to neoadjuvant therapy consisting of therapy of docetaxel, carboplatin, trastuzumab, and pertuzumab (TCHP) yields a greater rate of pathologic complete response (pCR) (breast and nodes) than TCHP alone when administered to women with operable, hormone receptor-positive, HER2-positive breast cancer.

SECONDARY OBJECTIVES:

I. To determine whether the addition of estrogen deprivation to neoadjuvant therapy consisting of TCHP will increase the pCR rate in the breast compared to TCHP alone when administered to women with operable, hormone receptor-positive, HER2-positive breast cancer.

II. To determine whether the addition of estrogen deprivation to neoadjuvant therapy consisting of TCHP improves recurrence-free interval (RFI) in women with operable, hormone receptor-positive, HER2-positive breast cancer.

III. To determine whether the addition of estrogen deprivation to neoadjuvant therapy consisting of TCHP improves overall survival (OS) in women with operable, hormone receptor-positive, HER2-positive breast cancer.

IV. To compare the rates of second primary invasive cancer by treatment arm.

V. Assessment of patterns of pCR, RFI, and OS by menopausal status.

VI. To evaluate the cardiac toxicity associated with each of the regimens.

VII. To compare the effect of adding estrogen deprivation to neoadjuvant therapy on endocrine-related symptoms in all patients by treatment arm.

VIII. To compare the effect of adding estrogen deprivation to neoadjuvant therapy on vasomotor symptoms, musculoskeletal, and vaginal complaints as well as quality of life.

IX. To determine a relationship between pCR and a potential mechanism of resistance/sensitivity in hormone receptor-positive, HER2-positive tumors.

OUTLINE: Patients are randomized to 1 of 2 treatments arms.

NEOADJUVANT:

ARM I: Patients receive docetaxel intravenously (IV) over 60 minutes, carboplatin IV over 30-60 minutes, trastuzumab IV over 30-90 minutes, and pertuzumab IV over 30-60 on day 1. Treatment repeats every 21 days for up to 6 courses in the absence of disease progression or unacceptable toxicity.

ARM II: All patients receive docetaxel, carboplatin, trastuzumab, and pertuzumab as in arm I. Premenopausal patients also receive goserelin acetate subcutaneously (SC) every 28 days until surgery and aromatase inhibition therapy at the investigator’s discretion daily until 1 day before surgery. Postmenopausal patients receive aromatase inhibition therapy at the investigator’s discretion daily until 1 day before surgery.

SURGERY: Patients undergo lumpectomy or mastectomy.

RADIATION: Patients undergo whole breast irradiation within 8 weeks following surgery.

ADJUVANT: Patients receive trastuzumab IV over 30-60 minutes every 21 days for up to 1 year.

After completion of study treatment, patients are followed up for 5 years.

Eligibility Criteria

Inclusion Criteria:

Women of reproductive potential must agree to use an effective non-hormonal method of contraception during study therapy (chemotherapy, trastuzumab, pertuzumab, and estrogen deprivation therapy) and for at least 7 months after the last dose of study therapy

Aspartate aminotransferase (AST) must be =< 1.5 x ULN for the lab

Total bilirubin must be =< upper limit of normal (ULN) for the lab unless the patient has a bilirubin elevation > ULN to 1.5 x ULN due to Gilbert’s disease or similar syndrome involving slow conjugation of bilirubin

Submission of tumor samples is required for all patients; the local pathology department policy regarding release of tumor samples must be considered in the screening process; patients whose tumor samples are located in a pathology department that by policy will not submit any samples for research purposes should not be approached for participation in the B-52 trial

Patients should have a life expectancy of at least 10 years, excluding their diagnosis of breast cancer; (comorbid conditions should be taken into consideration, but not the diagnosis of breast cancer)

Clinical staging for the primary tumor can be cT1c (must be 2.0 cm) or T2–T4 if clinically node negative; if the regional lymph nodes are cN1 and cytologically or histologically positive or if cN2–N3 with or without a biopsy, the primary breast tumor can be cT0–T4

The diagnosis of invasive adenocarcinoma of the breast must have been made by core needle biopsy

The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1

Absolute neutrophil count (ANC) must be >= 1200/mm^3

Platelet count must be >= 100,000/mm^3

Hemoglobin must be >= 10 g/dL

The tumor must have been determined to be HER2-postive as follows:

Immunohistochemistry (IHC) 3+ or

In situ hybridization (ISH)-positive (defined by ratio of HER2 to circulating endothelial progenitors [CEP]17 >= 2.0 or HER2 gene copy number >= 6 per nucleus)

The tumor must have been determined to be estrogen receptor (ER) and/or progesterone (PgR) positive assessed by current American Society of Clinical Oncology (ASCO)/College of American Pathologist (CAP) guideline recommendations for hormone receptor testing; patients with >= 1% ER or PgR staining by IHC are considered positive

Alkaline phosphatase must be =< 2.5 x ULN for the lab

Patients with AST or alkaline phosphatase > ULN are eligible for inclusion in the study if liver imaging (computed tomography [CT], MRI, positron emission tomography [PET]-CT, or PET scan) performed within 6 weeks prior to randomization does not demonstrate metastatic disease and the requirements are met

Alkaline phosphatase and AST may not both be > the ULN; for example, if the alkaline phosphatase is > the ULN but =< 2.5 x ULN, the AST must be =< the ULN; if the AST is > the ULN but =< 1.5 x ULN, the alkaline phosphatase must be =< ULN; Note: If alanine aminotransferase (ALT) is performed instead of AST (per institution's standard practice), the ALT value must be =< 1.5 x ULN; if both were performed, the AST must be =< 1.5 x ULN

Patients with alkaline phosphatase that is > ULN but =< 2.5 x ULN or unexplained bone pain are eligible for inclusion in the study if a bone scan, PET-CT scan, or PET scan performed within 6 weeks prior to randomization does not demonstrate metastatic disease

Within 6 weeks prior to randomization, the most recent serum creatinine must be =< ULN or measured or calculated creatinine clearance must be > 60 mL/min

The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines

Ipsilateral axillary lymph nodes must be evaluated by imaging (mammogram, ultrasound, and/or magnetic resonance imaging [MRI]) within 6 weeks prior to randomization; if suspicious or abnormal, fine needle aspirate (FNA) or core biopsy is recommended, also within 6 weeks prior to randomization; findings of these evaluations will be used to determine the nodal status prior to randomization:

Nodal status – negative

  • Imaging of the axilla is negative
  • Imaging is suspicious or abnormal but the FNA or core biopsy of the questionable node(s) on imaging is negative

Nodal status – positive

  • FNA or core biopsy of the node(s) is cytologically or histologically suspicious or positive
  • Imaging is suspicious or abnormal but FNA or core biopsy was not performed

Patients may be premenopausal or postmenopausal at the time of randomization; for study purposes, postmenopausal is defined as:

Age 56 or older with no spontaneous menses for at least 12 months prior to study entry; or

Age 55 or younger with no spontaneous menses for at least 12 months prior to study entry (e.g., spontaneous or secondary to hysterectomy) and with a documented estradiol level in the postmenopausal range according to local institutional/laboratory standard; or

Documented bilateral oophorectomy

Left ventricular ejection fraction (LVEF) assessment must be performed within 3 months prior to randomization; (LVEF assessment performed by 2-dimensional [2-D] echocardiogram is preferred; however, multi gated acquisition scan [MUGA] scan may be substituted based on institutional preferences); the LVEF must be >= 50% regardless of the cardiac imaging facility's lower limit of normal; note: since the pre-entry LVEF serves as the baseline for comparing subsequent LVEF assessments, it is critical that this baseline study be an accurate assessment; if the baseline LVEF is > 65%, the investigator is encouraged to have the accuracy of the initial LVEF result confirmed and repeat the test if the accuracy is uncertain

Exclusion Criteria:

FNA alone to diagnose the breast cancer

Active hepatitis B or hepatitis C with abnormal liver function tests

Chronic daily treatment with corticosteroids with a dose of >= 10 mg/day methylprednisolone equivalent (excluding inhaled steroids)

Previous endocrine therapy such as raloxifene or tamoxifen (or other selective estrogen receptor modulator [SERM]) or an aromatase inhibitor for any malignancy

Synchronous or previous contralateral invasive breast cancer; (patients with synchronous and/or previous contralateral ductal carcinoma in situ [DCIS] or lobular carcinoma in situ [LCIS] are eligible)

Previous therapy with anthracycline, taxanes, carboplatin, trastuzumab, or other HER2 targeted therapies for any malignancy

Treatment including radiation therapy (RT), chemotherapy, targeted therapy, or endocrine therapy for the currently diagnosed breast cancer prior to randomization

Intrinsic lung disease resulting in dyspnea

Poorly controlled diabetes mellitus

Patients known to be human immunodeficiency virus (HIV) positive with a baseline cluster of differentiation (CD)4 count of < 250 cells/mm^3 or have a history of acquired immune deficiency syndrome (AIDS) indicator conditions; patients taking anti-retroviral therapy that may have a potential overlapping toxicity with the study therapy are not eligible

Any previous history of ipsilateral invasive breast cancer or ipsilateral DCIS; (patients with synchronous or previous ipsilateral LCIS are eligible)

History of non-breast malignancies (except for in situ cancers treated only by local excision and basal cell and squamous cell carcinomas of the skin) within 5 years prior to randomization

Uncontrolled hypertension defined as sustained systolic blood pressure (BP) > 150 mmHg or diastolic BP > 90 mmHg; (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)

Active infection or chronic infection requiring chronic suppressive antibiotics

Definitive clinical or radiologic evidence of metastatic disease; (chest imaging [mandatory for all patients] and other imaging [if required] must have been performed within 90 days prior to randomization)

Synchronous bilateral invasive breast cancer

Conditions that would prohibit administration of corticosteroids

Known hypersensitivity to any of the study drugs or any of the ingredients or excipients of these drugs (e.g., polysorbate 80), including sensitivity to benzyl alcohol

Pregnancy or lactation at the time of study entry; (note: pregnancy testing must be performed within 2 weeks prior to randomization according to institutional standards for women of childbearing potential)

Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements

Use of any investigational product within 30 days prior to randomization

Malabsorption syndrome, ulcerative colitis, resection of the stomach or small bowel, or other disease significantly affecting gastrointestinal function

Other non-malignant systemic disease that would preclude treatment with any of the treatment regimens or would prevent required follow-up

Cardiac disease (history of and/or active disease) that would preclude the use of the drugs included in the treatment regimens; this includes but is not confined to:

Active cardiac disease:

  • Angina pectoris that requires the use of anti-anginal medication;
  • Ventricular arrhythmias except for benign premature ventricular contractions;
  • Supraventricular and nodal arrhythmias requiring a pacemaker or not controlled with medication;
  • Conduction abnormality requiring a pacemaker;
  • Valvular disease with documented compromise in cardiac function; and
  • Symptomatic pericarditis

History of cardiac disease:

  • Myocardial infarction documented by elevated cardiac enzymes or persistent regional wall abnormalities on assessment of left ventricular (LV) function;
  • History of documented congestive heart failure (CHF); and
  • Documented cardiomyopathy

Nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade 2, per the Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0)

Surgical axillary staging procedure prior to randomization; pre-neoadjuvant therapy sentinel node biopsy is not permitted

Any sex hormonal therapy, e.g., birth control pills, ovarian hormone replacement therapy, etc. (these patients are eligible if this therapy is discontinued prior to randomization)

Excisional biopsy or lumpectomy performed prior to randomization

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

National Cancer Institute

  • National Cancer Institute
Mothaffar Fahed Rimawi, Principal Investigator

Trial Sites

U.S.A.

Alaska
Fairbanks

Fairbanks Memorial Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

California
Anaheim

Kaiser Permanente-Anaheim

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Antioch

Kaiser Permanente-Deer Valley Medical Center

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Auburn

Sutter Auburn Faith Hospital

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Auburn

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Baldwin Park

Kaiser Permanente-Baldwin Park

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Bellflower

Kaiser Permanente-Bellflower

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Berkeley

Alta Bates Summit Medical Center-Herrick Campus

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Burlingame

Mills - Peninsula Hospitals

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Cameron Park

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Davis

Sutter Davis Hospital

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Fontana

Kaiser Permanente Hospital

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Fremont

Kaiser Permanente-Fremont

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Fresno

Kaiser Permanente

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Harbor City

Kaiser Permanente - Harbor City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Irvine

Kaiser Permanente-Irvine

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Loma Linda

Loma Linda University Medical Center

Gayathri Nagaraj
Ph: 909-558-3375

Gayathri Nagaraj
Principal Investigator

Los Angeles

Cedars-Sinai Medical Center

M. William Audeh
Ph: 310-423-8965

M. William Audeh
Principal Investigator

Kaiser Permanente Los Angeles Medical Center

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Kaiser Permanente-Cadillac

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Memorial Medical Center

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Mountain View

Palo Alto Medical Foundation-Camino Division

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Palo Alto Medical Foundation-Gynecologic Oncology

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Novato

Sutter Cancer Research Consortium

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Oakland

Kaiser Permanente-Oakland

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Orange

Saint Joseph Hospital - Orange

Timothy E. Byun
Ph: 714-734-6220

Timothy E. Byun
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Stanford Cancer Institute

Irene Leonor Wapnir
Ph: 650-498-7061
Email: clinicaltrials@med.stanford.edu

Irene Leonor Wapnir
Principal Investigator

Panorama City

Kaiser Permanente - Panorama City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Pismo Beach

Palchak David MD

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Riverside

Kaiser Permanente-Riverside

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Sutter Roseville Medical Center

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Kaiser Permanente-South Sacramento

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter General Hospital

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

San Diego

Kaiser Permanente-San Diego Mission

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Kaiser Permanente-San Diego Zion

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

San Francisco

California Pacific Medical Center-Pacific Campus

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Kaiser Permanente-San Francisco

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

San Marcos

Kaiser Permanente-San Marcos

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Pacific Medical Foundation

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sunnyvale

Palo Atlo Medical Foundation-Sunnyvale

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Vacaville

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Sutter Solano Medical Center/Cancer Center

Stacy D. D'Andre
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Stacy D. D'Andre
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Woodland Hills

Kaiser Permanente

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Colorado
Aurora

Rocky Mountain Cancer Centers-Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

The Medical Center of Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

University of Colorado Cancer Center - Anschutz Cancer Pavilion

Anthony David Elias
Ph: 720-848-0650

Anthony David Elias
Principal Investigator

Boulder

Boulder Community Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Springs

Memorial Hospital Colorado Springs

Anthony David Elias
Ph: 720-848-0650

Anthony David Elias
Principal Investigator

Penrose-Saint Francis Healthcare

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Denver

Colorado Blood Cancer Institute

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Cancer Research Program CCOP

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Exempla Saint Joseph Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Porter Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Presbyterian - Saint Lukes Medical Center - Health One

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Midtown

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Rose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rose Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Durango

Mercy Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Southwest Oncology PC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Englewood

Comprehensive Cancer Care and Research Institute of Colorado LLC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Swedish Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Fort Collins

Poudre Valley Hospital

Anthony David Elias
Ph: 720-848-0650

Anthony David Elias
Principal Investigator

Golden

Mountain Blue Cancer Care Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greeley

North Colorado Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greenwood Village

Rocky Mountain Cancer Centers-Greenwood Village

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Anthony Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Littleton

Littleton Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Littleton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lone Tree

Rocky Mountain Cancer Centers-Sky Ridge

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Sky Ridge Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Longmont

Longmont United Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Longmont

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Loveland

McKee Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Parker

Parker Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Parker

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Pueblo

Rocky Mountain Cancer Centers - Pueblo

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Mary Corwin Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Thornton

Rocky Mountain Cancer Centers-Thornton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Wheat Ridge

SCL Health Lutheran Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Connecticut
Hartford

Saint Francis Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Delaware
Lewes

Beebe Medical Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Newark

Christiana Care Health System-Christiana Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Christiana Gynecologic Oncology LLC

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Delaware Clinical and Laboratory Physicians PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Helen F Graham Cancer Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Medical Oncology Hematology Consultants PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Regional Hematology and Oncology PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Rehoboth Beach

Beebe Health Campus

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Seaford

Nanticoke Memorial Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Wilmington

Christiana Care Health System-Wilmington Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

District of Columbia
Washington

MedStar Georgetown University Hospital

Edward C. McCarron
Ph: 443-777-7364

Edward C. McCarron
Principal Investigator

Washington Hospital Center

Edward C. McCarron
Ph: 443-777-7364

Edward C. McCarron
Principal Investigator

Florida
Deerfield Beach

University of Miami Sylvester Comprehensive Cancer Center at Deerfield Beach

Judith Hurley
Ph: 866-574-5124
Email: Sylvester@emergingmed.com

Judith Hurley
Principal Investigator

Gainesville

University of Florida

Karen Colleen Daily
Ph: 352-273-8675
Email: trials@cancer.ufl.edu

Karen Colleen Daily
Principal Investigator

Miami

University of Miami Miller School of Medicine-Sylvester Cancer Center

Judith Hurley
Ph: 866-574-5124
Email: Sylvester@emergingmed.com

Judith Hurley
Principal Investigator

Orlando

UF Cancer Center at Orlando Health

Regan D. Rostorfer
Ph: 321-841-7246
Email: CancerClinicalTrials@orlandohealth.com

Regan D. Rostorfer
Principal Investigator

Georgia
Athens

University Cancer and Blood Center LLC

Sharad Anant Ghamande
Ph: 706-721-1663
Email: cancer@georgiahealth.edu

Sharad Anant Ghamande
Principal Investigator

Atlanta

Northside Hospital

Cheryl F. Jones
Ph: 404-303-3355

Cheryl F. Jones
Principal Investigator

Augusta

Georgia Regents University Medical Center

Sharad Anant Ghamande
Ph: 706-721-1663
Email: cancer@georgiahealth.edu

Sharad Anant Ghamande
Principal Investigator

Cumming

Northside Hospital-Forsyth

Cheryl F. Jones
Ph: 404-303-3355

Cheryl F. Jones
Principal Investigator

Decatur

Dekalb Medical Center

Jayanthi Srinivasiah
Ph: 404-501-3279

Jayanthi Srinivasiah
Principal Investigator

Gainesville

Northeast Georgia Medical Center

Richard John LoCicero
Ph: 770-219-8800
Email: cancerpatient.navigator@nghs.com

Richard John LoCicero
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Mark Alexander Taylor
Ph: 912-350-8568

Mark Alexander Taylor
Principal Investigator

Low Country Cancer Care Associates PC

Christopher E. Haberman
Ph: 912-350-8568

Christopher E. Haberman
Principal Investigator

Memorial University Medical Center

Christopher E. Haberman
Ph: 912-350-8568

Christopher E. Haberman
Principal Investigator

Summit Cancer Care-Memorial

Christopher E. Haberman
Ph: 912-350-8568

Christopher E. Haberman
Principal Investigator

Hawaii
Aiea

Oncare Hawaii Inc-Pali Momi

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Pali Momi Medical Center

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Ewa Beach

The Cancer Center of Hawaii-Leeward

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Honolulu

Kaiser Permanente Moanalua Medical Center

Louis Fehrenbacher
Ph: 626-564-3455

Louis Fehrenbacher
Principal Investigator

Kuakini Medical Center

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Oncare Hawaii Inc-Kuakini

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Oncare Hawaii Inc-POB II

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

OnCare Hawaii-Liliha

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Queen's Medical Center

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Straub Clinic and Hospital

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

The Cancer Center of Hawaii-Liliha

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

University of Hawaii Cancer Center

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Lihue

Wilcox Memorial Hospital and Kauai Medical Clinic

Kenneth N.M. Sumida
Ph: 808-586-2979
Email: dorothy@crch.hawaii.edu

Kenneth N.M. Sumida
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Coeur D'Alene

Kootenai Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Post Falls

Kootenai Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Sandpoint

Kootenai Cancer

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Illinois
Aurora

Rush - Copley Medical Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Bloomington

Illinois CancerCare-Bloomington

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Saint Joseph Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Canton

Illinois CancerCare-Canton

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Carbondale

Memorial Hospital of Carbondale

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Carthage

Illinois CancerCare-Carthage

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Centralia

Centralia Oncology Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Chicago

John H Stroger Jr Hospital of Cook County

Thomas E. Lad
Ph: 312-864-6000

Thomas E. Lad
Principal Investigator

Mount Sinai Hospital Medical Center

Pam G. Khosla
Ph: 773-257-5960
Email: suhi@sinai.org

Pam G. Khosla
Principal Investigator

University of Illinois

Oana Cristina Danciu
Ph: 312-355-3046

Oana Cristina Danciu
Principal Investigator

Danville

Carle on Vermilion

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Decatur

Cancer Care Center of Decatur

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Decatur Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Effingham

Carle Physician Group-Effingham

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Crossroads Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Eureka

Illinois CancerCare-Eureka

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Galesburg

Illinois CancerCare Galesburg

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Western Illinois Cancer Treatment Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Harvey

Ingalls Memorial Hospital

Mark Farrell Kozloff
Ph: 708-915-4673
Email: clinicaltrials@ingalls.org

Mark Farrell Kozloff
Principal Investigator

Kankakee

Presence Saint Mary's Hospital

Silviya V. Velinova
Ph: 815-937-8780

Silviya V. Velinova
Principal Investigator

Kewanee

Illinois CancerCare-Kewanee Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Macomb

Illinois CancerCare-Macomb

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Mattoon

Carle Physician Group-Mattoon/Charleston

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Mount Vernon

Good Samaritan Regional Health Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Naperville

Edward Hospital/Cancer Center

Joseph J. Kash
Ph: 630-646-6075

Joseph J. Kash
Principal Investigator

Ottawa

Illinois CancerCare-Ottawa Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Radiation Oncology of Northern Illinois

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Pekin

Illinois CancerCare-Pekin

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Pekin Cancer Treatment Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Peoria

Illinois CancerCare-Peoria

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Methodist Medical Center of Illinois

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

OSF Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Peru

Illinois CancerCare-Peru

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Valley Radiation Oncology

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Plainfield

Edward Hospital/Cancer Center?Plainfield

Joseph J. Kash
Ph: 630-646-6075

Joseph J. Kash
Principal Investigator

Princeton

Illinois CancerCare-Princeton

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Rockford

Saint Anthony Medical Center

Shylendra B. Sreenivasappa
Ph: 815-227-2633

Shylendra B. Sreenivasappa
Principal Investigator

SwedishAmerican Regional Cancer Center/ACT

Harvey E. Einhorn
Ph: 779-696-9400
Email: cancercare@swedishamerican.org

Harvey E. Einhorn
Principal Investigator

Springfield

Central Illinois Hematology Oncology Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Memorial Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southern Illinois University School of Medicine

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Swansea

Cancer Care Specialists of Illinois-Swansea

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Urbana

Carle Cancer Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

The Carle Foundation Hospital

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Warrenville

Cadence Cancer Center in Warrenville

Perry J. Menini
Ph: 630-208-4563
Email: kevin.tomczyk@delnor.com

Perry J. Menini
Principal Investigator

Yorkville

Rush-Copley Healthcare Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Indiana
Crown Point

Michiana Hematology Oncology PC-Crown Point

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Elkhart

Michiana Hematology Oncology PC-Elkhart

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Indianapolis

Franciscan Saint Francis Health-Indianapolis

Sarah Ali
Ph: 317-851-2555

Sarah Ali
Principal Investigator

Michigan City

Franciscan Saint Anthony Health-Michigan City

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Woodland Cancer Care Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Mishawaka

Michiana Hematology Oncology PC-Mishawaka

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Saint Joseph Regional Medical Center-Mishawaka

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Munster

The Community Hospital

Erwin L. Robin
Ph: 708-915-4673
Email: clinicaltrials@ingalls.org

Erwin L. Robin
Principal Investigator

Plymouth

Michiana Hematology Oncology PC-Plymouth

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Richmond

Reid Hospital and Health Care Services

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

South Bend

Michiana Hematology Oncology PC-South Bend

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Northern Indiana Cancer Research Consortium CCOP

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Westville

Michiana Hematology Oncology PC-Westville

Bilal Ansari
Ph: 574-237-1328

Bilal Ansari
Principal Investigator

Iowa
Ames

Mary Greeley Medical Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

McFarland Clinic PC-William R Bliss Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Boone

McFarland Clinic PC-Boone

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Cancer Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Council Bluffs

Alegent Health Mercy Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Des Moines

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Medical Center - Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Fort Dodge

McFarland Clinic PC-Trinity Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Iowa City

University of Iowa/Holden Comprehensive Cancer Center

Alexandra Thomas
Ph: 800-237-1225

Alexandra Thomas
Principal Investigator

Jefferson

McFarland Clinic PC-Jefferson

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Marshalltown

McFarland Clinic PC-Marshalltown

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

West Des Moines

Mercy Medical Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kansas
Chanute

Cancer Center of Kansas - Chanute

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Dodge City

Cancer Center of Kansas - Dodge City

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

El Dorado

Cancer Center of Kansas - El Dorado

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kingman

Cancer Center of Kansas-Kingman

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Liberal

Cancer Center of Kansas-Liberal

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Newton

Cancer Center of Kansas - Newton

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Parsons

Cancer Center of Kansas - Parsons

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Pratt

Cancer Center of Kansas - Pratt

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Salina

Cancer Center of Kansas - Salina

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Wellington

Cancer Center of Kansas - Wellington

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Wichita

Associates In Womens Health

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas - Main Office

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas-Wichita Medical Arts Tower

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Via Christi Regional Medical Center

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Winfield

Cancer Center of Kansas - Winfield

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kentucky
Bardstown

Flaget Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Corbin

Baptist Health Corbin

Peter Spalding Tate
Ph: 859-260-6425

Peter Spalding Tate
Principal Investigator

Commonwealth Cancer Center-Corbin

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Crestview Hills

Oncology Hematology Care Inc-Crestview

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Elizabethtown

Hardin Memorial Hospital

Peter Spalding Tate
Ph: 859-260-6425

Peter Spalding Tate
Principal Investigator

Lexington

Baptist Health Lexington

Peter Spalding Tate
Ph: 859-260-6425

Peter Spalding Tate
Principal Investigator

Saint Joseph Hospital East

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saint Joseph Radiation Oncology Resource Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

University of Kentucky/Markey Cancer Center

Edward H. Romond
Ph: 859-257-3379

Edward H. Romond
Principal Investigator

Louisville

Jewish Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Jewish Hospital Medical Center Northeast

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saints Mary and Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

The James Graham Brown Cancer Center at University of Louisville

Elizabeth Carloss Riley
Ph: 866-530-5516

Elizabeth Carloss Riley
Principal Investigator

Madisonville

Baptist Health Madisonville/Merle Mahr Cancer Center

Peter Spalding Tate
Ph: 859-260-6425

Peter Spalding Tate
Principal Investigator

Paducah

Baptist Health Paducah

Peter Spalding Tate
Ph: 859-260-6425

Peter Spalding Tate
Principal Investigator

Shepherdsville

Jewish Hospital Medical Center South

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Louisiana
Baton Rouge

Ochsner Health Center-Summa

John Thomas Cole
Ph: 888-562-4763

John Thomas Cole
Principal Investigator

Kenner

Ochsner Medical Center Kenner

John Thomas Cole
Ph: 888-562-4763

John Thomas Cole
Principal Investigator

New Orleans

Ochsner Medical Center Jefferson

John Thomas Cole
Ph: 888-562-4763

John Thomas Cole
Principal Investigator

Maine
Bangor

Eastern Maine Medical Center

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Brewer

Lafayette Family Cancer Center-EMMC

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Maryland
Baltimore

Greater Baltimore Medical Center

Madhu Chaudhry
Ph: 443-849-3706

Madhu Chaudhry
Principal Investigator

MedStar Franklin Square Medical Center/Weinberg Cancer Institute

Edward C. McCarron
Ph: 443-777-7364

Edward C. McCarron
Principal Investigator

Elkton MD

Union Hospital of Cecil County

Timothy Francis Wozniak
Ph: 443-406-1374
Email: bmoney@uhcc.com

Timothy Francis Wozniak
Principal Investigator

Frederick

Frederick Memorial Hospital

Brian Marcial O'Connor
Ph: 240-566-3584
Email: clinicaltrials@fmh.org

Brian Marcial O'Connor
Principal Investigator

Massachusetts
Fall River

Saint Anne's Hospital

Peter R. Ward
Ph: 508-674-5600ext2515

Peter R. Ward
Principal Investigator

Pittsfield

Berkshire Hematology Oncology PC

Harvey Zimbler
Ph: 413-496-8205
Email: ggero@bhs1.org

Harvey Zimbler
Principal Investigator

Michigan
Ann Arbor

Saint Joseph Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Dearborn

Oakwood Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Detroit

Saint John Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Wayne State University/Karmanos Cancer Institute

Michael Steven Simon
Ph: 313-576-9363

Michael Steven Simon
Principal Investigator

Farmington

Botsford General Hospital

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Farmington Hills

Weisberg Cancer Treatment Center

Michael Steven Simon
Ph: 313-576-9363

Michael Steven Simon
Principal Investigator

Flint

Genesys Hurley Cancer Institute

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Hurley Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Jackson

Allegiance Health

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Kalamazoo

West Michigan Cancer Center

Sunil Nagpal
Ph: 269-373-7458

Sunil Nagpal
Principal Investigator

Lansing

Sparrow Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Livonia

Saint Mary Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Midland

Mid-Michigan Medical Center - Midland

Michel Rene Hurtubise
Ph: 989-839-3377

Michel Rene Hurtubise
Principal Investigator

Pontiac

Saint Joseph Mercy Oakland

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Port Huron

Saint Joseph Mercy Port Huron

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Roseville

Michigan Cancer Specialists

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Royal Oak

Cancer Care Associates PC

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Comprehensive Medical Center PLLC

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Hematology Oncology Consultants PC

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Oakland Colon and Rectal Association

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Oakland Medical Group

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

William Beaumont Hospital-Royal Oak

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Saginaw

Saint Mary's of Michigan

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Sterling Heights

Mitchell Folbe MD PC

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Premier Hematology Oncology Care

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Troy

Claudia BR Herke MD PC

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Hematology Oncology Consultants PC-Troy

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Michigan Institute of Urology-Town Center

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

William Beaumont Hospital - Troy

Eric Allen Brown
Ph: 248-551-7695

Eric Allen Brown
Principal Investigator

Warren

Saint John Macomb-Oakland Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Minnesota
Bemidji

Sanford Clinic North-Bemidgi

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Burnsville

Fairview Ridges Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Coon Rapids

Mercy Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Edina

Fairview-Southdale Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Fridley

Unity Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Maplewood

Minnesota Oncology Hematology PA-Maplewood

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Saint John's Hospital - Healtheast

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Minneapolis

Abbott-Northwestern Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Health Partners Inc

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Hennepin County Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

New Ulm

New Ulm Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Robbinsdale

North Memorial Medical Health Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Saint Louis Park

Park Nicollet Clinic - Saint Louis Park

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Saint Paul

Regions Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

United Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Stillwater

Lakeview Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Waconia

Ridgeview Medical Center

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Willmar

Rice Memorial Hospital

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Woodbury

Minnesota Oncology and Hematology PA-Woodbury

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Missouri
Bolivar

Central Care Cancer Center-Carrie J Babb Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Bonne Terre

Parkland Health Center-Bonne Terre

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Branson

CoxHealth Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Columbia

University of Missouri - Ellis Fischel

Akm Mosharraf Hossain
Ph: 573-882-7440

Akm Mosharraf Hossain
Principal Investigator

Jefferson City

Capital Region Medical Center-Goldschmidt Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Joplin

Freeman Health System

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital-Joplin

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Rolla

Phelps County Regional Medical Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint John's Clinic-Rolla-Cancer and Hematology

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint Louis

Mercy Hospital Saint Louis

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Saint Louis Cancer and Breast Institute-South City

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield

CoxHealth South Hospital

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital Springfield

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Sullivan

Missouri Baptist Sullivan Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Montana
Billings

Billings Clinic Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Montana Cancer Consortium CCOP

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Saint Vincent Healthcare

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Butte

Saint James Community Hospital and Cancer Treatment Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Great Falls

Benefis Healthcare- Sletten Cancer Institute

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Helena

Saint Peter's Community Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Kalispell

Kalispell Regional Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Missoula

Community Medical Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Saint Patrick Hospital - Community Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kearney

CHI Health Good Samaritan

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Heartland Hematology and Oncology

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lincoln

Saint Elizabeth Regional Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Omaha

Alegent Health Bergan Mercy Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Immanuel Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Lakeside Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Creighton University Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Hemotology and Oncology Consultants PC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Papillion

Midlands Community Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Nevada
Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas

21st Century Oncology

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Children's Specialty Center of Nevada II

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Summerlin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Nevada Cancer Research Foundation CCOP

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Central

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Southeast

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Reno

Renown Regional Medical Center

Deepa Reddy Kausalya Mocherla
Ph: 775-982-4400

Deepa Reddy Kausalya Mocherla
Principal Investigator

New Hampshire
Lebanon

Dartmouth Hitchcock Medical Center

Gary N. Schwartz
Ph: 800-639-6918
Email: cancer.research.nurse@dartmouth.edu

Gary N. Schwartz
Principal Investigator

New Jersey
Newark

Newark Beth Israel Medical Center

Lori Schleicher
Ph: 973-926-7230

Lori Schleicher
Principal Investigator

Newton

Newton Memorial Hospital

Michael Joel Kane
Ph: 609-748-7200

Michael Joel Kane
Principal Investigator

Pompton

Chilton Memorial Hospital

Michael Joel Kane
Ph: 609-748-7200

Michael Joel Kane
Principal Investigator

Summit

Overlook Hospital

Michael Joel Kane
Ph: 609-748-7200

Michael Joel Kane
Principal Investigator

Vineland

Inspira Medical Center Vineland

Shailja Roy
Ph: 856-641-7933

Shailja Roy
Principal Investigator

Woodbury

Inspira Medical Center Woodbury

Shailja Roy
Ph: 856-641-7933

Shailja Roy
Principal Investigator

New Mexico
Albuquerque

University of New Mexico

Ursa A. Brown-Glaberman
Ph: 505-272-6972

Ursa A. Brown-Glaberman
Principal Investigator

Las Cruces

Memorial Medical Center - Las Cruces

Ursa A. Brown-Glaberman
Ph: 505-272-6972

Ursa A. Brown-Glaberman
Principal Investigator

New York
New York

Columbia University Medical Center

Katherine D. Crew
Ph: 212-305-8615

Katherine D. Crew
Principal Investigator

North Carolina
Asheboro

Randolph Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Asheville

Asheville Hematology-Oncology Associates

Raymond Thertulien
Ph: 855-774-5433

Raymond Thertulien
Principal Investigator

Burlington

Cone Health Cancer Center at Alamance Regional

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Clinton

Southeastern Medical Oncology Center-Clinton

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Goldsboro

Southeastern Medical Oncology Center-Goldsboro

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Wayne Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Greensboro

Cone Health Cancer Center

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Hendersonville

Park Ridge Hospital Breast Health Center

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

Jacksonville

Southeastern Medical Oncology Center-Jacksonville

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Kinston

Kinston Medical Specialists PA

Peter Robins Watson
Ph: 252-559-2200

Peter Robins Watson
Principal Investigator

Mebane

Cone Heath Cancer Center at Mebane

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Pinehurst

FirstHealth of the Carolinas-Moore Regional Hosiptal

Charles S. Kuzma
Ph: 910-715-2200

Charles S. Kuzma
Principal Investigator

Reidsville

Annie Penn Memorial Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Statesville

Iredell Memorial Hospital

Ruby Ann Grimm
Ph: 704-873-5661

Ruby Ann Grimm
Principal Investigator

Wilson

Southeastern Medical Oncology Center-Wilson

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Winston-Salem

Wake Forest University Health Sciences

Edward A. Levine
Ph: 336-713-6771

Edward A. Levine
Principal Investigator

North Dakota
Bismarck

Sanford Bismarck Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Fargo

Roger Maris Cancer Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Medical Center-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Grand Forks

Altru Cancer Center

Grant Richard Seeger
Ph: 701-780-6520

Grant Richard Seeger
Principal Investigator

Minot

Trinity Cancer Care Center

Patanit Watanaboonyakhet
Ph: 800-862-0005

Patanit Watanaboonyakhet
Principal Investigator

Ohio
Akron

Akron General Medical Center

Andrew H. Fenton
Ph: 330-344-6348

Andrew H. Fenton
Principal Investigator

Belpre

Strecker Cancer Center-Belpre

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Canton

Aultman Health Foundation

Shruti Trehan
Ph: 330-363-6891

Shruti Trehan
Principal Investigator

Centerville

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Chillicothe

Adena Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Cincinnati

Bethesda North Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Good Samaritan Hospital - Cincinnati

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Oncology Hematology Care Inc - Anderson

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc - Kenwood

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Blue Ash

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Eden Park

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Mercy West

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

The Christ Hospital

Robert L. Cody
Ph: 513-585-2859

Robert L. Cody
Principal Investigator

TriHealth Cancer Institute-Anderson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

TriHealth Cancer Institute-Westside

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

University of Cincinnati

Elizabeth Ann Shaughnessy
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Elizabeth Ann Shaughnessy
Principal Investigator

Columbus

Columbus Oncology and Hematology Associates Inc

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Doctors Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Grant Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Mount Carmel Health Center West

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Riverside Methodist Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

The Mark H Zangmeister Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Dayton

Good Samaritan Hospital - Dayton

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Samaritan North Health Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Delaware

Delaware Health Center-Grady Cancer Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Delaware Radiation Oncology

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Grady Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Fairfield

Oncology Hematology Care Inc-Healthplex

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Findlay

Blanchard Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Franklin

Atrium Medical Center-Middletown Regional Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Greenville

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Kettering

Kettering Medical Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Lancaster

Fairfield Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Marietta

Marietta Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Mount Vernon

Knox Community Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Newark

Licking Memorial Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Newark Radiation Oncology

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Portsmouth

Southern Ohio Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Springfield

Springfield Regional Cancer Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Springfield Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Troy

Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

West Chester

University Pointe

Elizabeth Ann Shaughnessy
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Elizabeth Ann Shaughnessy
Principal Investigator

Westerville

Saint Ann's Hospital

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Zanesville

Genesis HealthCare System

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Oklahoma
Lawton

Cancer Centers of Southwest Oklahoma Research

Nadim Fouad Nimeh
Ph: 877-231-4440

Nadim Fouad Nimeh
Principal Investigator

Pennsylvania
Beaver

UPMC-Heritage Valley Health System Beaver

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Clairton

UPMC Cancer Center at Jefferson Regional Medical Center

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Danville

Geisinger Medical Center

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Easton

Easton Hospital

Sonyo Shin
Ph: 610-250-4000

Sonyo Shin
Principal Investigator

Greensburg

UPMC Cancer Centers - Arnold Palmer Pavilion

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Hazleton

Geisinger Medical Center-Cancer Center Hazleton

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Hershey

Penn State Milton S Hershey Medical Center

Cristina I. Truica
Ph: 410-601-6120
Email: CTO@hmc.psu.edu

Cristina I. Truica
Principal Investigator

Johnstown

UPMC-Johnstown/John P. Murtha Regional Cancer Center

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Lewisburg

Geisinger Medical Oncology at Evangelical Community Hospital

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Lewistown

Lewistown Hospital

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

McKeesport

UPMC Cancer Center at UPMC McKeesport

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Monroeville

Forbes Hospital

Thomas Benjamin Julian
Ph: 877-284-2000

Thomas Benjamin Julian
Principal Investigator

Moon Township

UPMC-Coraopolis/Heritage Valley Radiation Oncology

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Pittsburgh

Allegheny General Hospital

Thomas Benjamin Julian
Ph: 877-284-2000

Thomas Benjamin Julian
Principal Investigator

University of Pittsburgh Cancer Institute (UPCI)

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Magee Womens Hospital

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Passavant Hospital

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Presbyterian Hospital

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Saint Clair Hospital Cancer Center

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Saint Margaret

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

UPMC-Shadyside Hospital

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

West Penn Hospital

Thomas Benjamin Julian
Ph: 877-284-2000

Thomas Benjamin Julian
Principal Investigator

Pottsville

Geisinger Medical Oncology-Pottsville

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Seneca

UPMC Cancer Center at UPMC Northwest

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

State College

Geisinger Medical Group

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Uniontown

UPMC Uniontown Hospital Radiation Oncology

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

Washington

UPMC Washington Hospital Radiation Oncology

Adam Matthew Brufsky
Ph: 412-647-2811

Adam Matthew Brufsky
Principal Investigator

West Chester

Chester County Hospital

William Emil Luginbuhl
Ph: 610-431-5297

William Emil Luginbuhl
Principal Investigator

West Reading

Reading Hospital

Terrence Paul Cescon
Ph: 610-988-9323

Terrence Paul Cescon
Principal Investigator

Wilkes-Barre

Geisinger Wyoming Valley/Henry Cancer Center

Victor G. Vogel
Ph: 570-271-5251

Victor G. Vogel
Principal Investigator

Williamsport

Susquehanna Cancer Center

Warren Lewis Robinson
Ph: 800-598-4282

Warren Lewis Robinson
Principal Investigator

Rhode Island
Providence

Women and Infants Hospital

Bachir J. Sakr
Ph: 401-274-1122

Bachir J. Sakr
Principal Investigator

Warwick

Kent County Hospital

Candace L. Dyer
Ph: 401-737-7010

Candace L. Dyer
Principal Investigator

South Carolina
Easley

Greenville Health System Cancer Institute-Easley

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Georgetown

Georgetown Hospital System

Megan Keeffe Baker Ruppel
Ph: 843-792-9321

Megan Keeffe Baker Ruppel
Principal Investigator

Greenville

Greenville Health System Cancer Institute-Andrews

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Butternut

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Memorial Hospital

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Saint Francis Cancer Center

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Saint Francis Hospital

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Greer

Gibbs Cancer Center-Pelham

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

Greenville Health System Cancer Institute-Greer

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Lancaster

Carolina Blood and Cancer Care Associates PA-Lancaster

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

Rock Hill

Carolina Blood and Cancer Care Associates PA

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg Medical Center

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

Union

MGC Hematology Oncology-Union

Steven William Corso
Ph: 800-486-5941

Steven William Corso
Principal Investigator

South Dakota
Sioux Falls

Avera Cancer Institute

Amy K. Krie
Ph: 800-657-4377
Email: Jan.Healy@avera.org

Amy K. Krie
Principal Investigator

Sanford Cancer Center-Oncology Clinic

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford USD Medical Center - Sioux Falls

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Tennessee
Chattanooga

Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Hixson

Pulmonary Medicine Center of Chattanooga-Hixson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Jackson

Jackson-Madison County General Hospital

Dwight C. Kaufman
Ph: 731-425-6865

Dwight C. Kaufman
Principal Investigator

Ooltewah

Memorial GYN Plus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Texas
Houston

Baylor College of Medicine

Mothaffar Fahed Rimawi
Ph: 713-798-1354
Email: burton@bcm.edu

Mothaffar Fahed Rimawi
Principal Investigator

Ben Taub General Hospital

Mothaffar Fahed Rimawi
Ph: 713-798-1354
Email: burton@bcm.edu

Mothaffar Fahed Rimawi
Principal Investigator

San Antonio

University Hospital

Kate Ida Lathrop
Ph: 210-450-3800

Kate Ida Lathrop
Principal Investigator

University of Texas Health Science Center at San Antonio

Kate Ida Lathrop
Ph: 210-450-3800

Kate Ida Lathrop
Principal Investigator

Virginia
Fredericksburg

Hematology Oncology Associates of Fredericksburg Inc

Harry Douglas Bear
Ph: 804-628-1939

Harry Douglas Bear
Principal Investigator

Mechanicsville

Bon Secours Memorial Regional Medical Center

William Johnson Irvin
Ph: 804-594-4900

William Johnson Irvin
Principal Investigator

Midlothian

Bon Secours Saint Francis Medical Center

William Johnson Irvin
Ph: 804-594-4900

William Johnson Irvin
Principal Investigator

Richmond

Bon Secours Saint Mary's Hospital

William Johnson Irvin
Ph: 804-594-4900

William Johnson Irvin
Principal Investigator

Virginia Commonwealth University/Massey Cancer Center

Harry Douglas Bear
Ph: 804-628-1939

Harry Douglas Bear
Principal Investigator

South Hill

VCU Community Memorial Health Center

Harry Douglas Bear
Ph: 804-628-1939

Harry Douglas Bear
Principal Investigator

Winchester

Shenandoah Oncology Associates PC

Harry Douglas Bear
Ph: 804-628-1939

Harry Douglas Bear
Principal Investigator

Washington
Auburn

MultiCare Auburn Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bainbridge Island

Virginia Mason Bainbridge Island Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bellevue

Overlake Hospital Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bremerton

Harrison HealthPartners Hematology and Oncology-Bremerton

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Harrison Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Burien

Highline Medical Center-Main Campus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Enumclaw

Saint Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Federal Way

Saint Francis Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Virginia Mason Federal Way Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Gig Harbor

MultiCare Gig Harbor Medical Park

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Gig Harbor

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Kennewick

Northwest Cancer Clinic

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Lakewood

Saint Clare Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lynnwood

Virginia Mason Lynnwood Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Poulsbo

Harrison HealthPartners Hematology and Oncology-Poulsbo

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Peninsula Cancer Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Puyallup

MultiCare Good Samaritan Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Puyallup

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Seattle

Virginia Mason Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma

Franciscan Research Center-Northwest Medical Plaza

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Multicare Health System

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Northwest Medical Specialties PLLC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Jackson Hall

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Saint Joe's

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

West Virginia
Bridgeport

United Hospital Center

Mohamad Adham Salkeni
Ph: 304-293-2745
Email: sfilburn@hsc.wvu.edu

Mohamad Adham Salkeni
Principal Investigator

Charleston

West Virginia University Charleston

Steven James Jubelirer
Ph: 304-344-3457

Steven James Jubelirer
Principal Investigator

Martinsburg

City Hospital

Mohamad Adham Salkeni
Ph: 304-293-2745
Email: sfilburn@hsc.wvu.edu

Mohamad Adham Salkeni
Principal Investigator

Morgantown

Monongalia Hospital

Jamie L. Lesnock
Ph: 888-823-5923
Email: ctsucontact@westat.com

Jamie L. Lesnock
Principal Investigator

West Virginia University Healthcare

Mohamad Adham Salkeni
Ph: 304-293-2745
Email: sfilburn@hsc.wvu.edu

Mohamad Adham Salkeni
Principal Investigator

Parkersburg

Camden-Clark Memorial Hospital

Mohamad Adham Salkeni
Ph: 304-293-2745
Email: sfilburn@hsc.wvu.edu

Mohamad Adham Salkeni
Principal Investigator

Wisconsin
Burlington

Aurora Cancer Care-Burlington

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Chippewa Falls

Marshfield Clinic-Chippewa Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Sacred Heart Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Elkhorn

Aurora Cancer Care-Southern Lakes

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Fond Du Lac

Aurora Health Center-Fond du Lac

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Grafton

Aurora Cancer Care-Grafton

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Green Bay

Aurora BayCare Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Bellin Memorial Hospital

Patrick J. Mansky
Ph: 240-566-3584
Email: clinicaltrials@fmh.org

Patrick J. Mansky
Principal Investigator

Janesville

Mercy Health System

Emily Gray Robinson
Ph: 800-928-1103

Emily Gray Robinson
Principal Investigator

Kenosha

Aurora Cancer Care-Kenosha South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Ladysmith

Marshfield Clinic - Ladysmith Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Marinette

Vince Lombardi Cancer Clinic-Marinette

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Marshfield

Marshfield Clinic

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Saint Joseph's Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Milwaukee

Aurora Cancer Care-Milwaukee

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Cancer Care-Milwaukee South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Saint Luke's Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Sinai Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Froedtert and the Medical College of Wisconsin

Christopher R. Chitambar
Ph: 414-805-3666

Christopher R. Chitambar
Principal Investigator

Minocqua

Marshfield Clinic-Minocqua Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

New Richmond

Cancer Center of Western Wisconsin

Patrick James Flynn
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Patrick James Flynn
Principal Investigator

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Racine

Aurora Cancer Care-Racine

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Rhinelander

Marshfield Clinic at James Beck Cancer Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Saint Mary's Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Sheboygan

Vince Lombardi Cancer Clinic-Sheboygan

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Stevens Point

Marshfield Clinic Cancer Care at Saint Michael's Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Saint Michael's Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Summit

Aurora Medical Center in Summit

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Two Rivers

Vince Lombardi Cancer Clinic

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Waukesha

Aurora Cancer Care-Waukesha

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Wausau

Marshfield Clinic-Wausau Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Wauwatosa

Aurora Cancer Care-Milwaukee West

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

West Allis

Aurora West Allis Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Weston

Diagnostic and Treatment Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Marshfield Clinic - Weston Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Saint Clare's Hospital

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Wisconsin Rapids

Marshfield Clinic - Wisconsin Rapids Center

Douglas J. Reding
Ph: 715-389-4457

Douglas J. Reding
Principal Investigator

Wyoming
Cheyenne

Cheyenne Regional Medical Center-West

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Cody

Big Horn Basin Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Billings Clinic-Cody

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Sheridan

Welch Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT02003209

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.